• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

过氧化物酶体增殖物激活受体-β/δ对脓毒症诱导的急性肺损伤的影响。

Effects of peroxisome proliferator-activated receptor-β/δ on sepsis induced acute lung injury.

作者信息

Wang Cairui, Zhou Guopeng, Zeng Zeng

机构信息

Department of Geriatrics, Peking University First Hospital, Beijing 100034, China.

Department of Geriatrics, Peking University First Hospital, Beijing 100034, China. Email:

出版信息

Chin Med J (Engl). 2014;127(11):2129-37.

PMID:24890166
Abstract

BACKGROUND

Acute lung injury (ALI) and acute respiratory distress syndrome (ARDS) are the first steps in the development of multiple organ failure induced by sepsis. A systemic excessive inflammatory reaction is currently the accepted mechanism of the pathogenesis of sepsis. Several studies have suggested a protective role of the peroxisome proliferator activated receptor-β/δ (PPAR-β/δ) in related inflammatory diseases. But the role of PPARβ/δ in ALI remains uncertain. The aim of this study was to investigate the role and possible mechanism of PPARβ/δ in ALI induced by sepsis.

METHODS

Cecal ligation and puncture (CLP) was used as a sepsis model. Rats were randomly divided into four groups, the control group (CON, n = 6), sham-operation group (SHAM, n = 12), cecal ligation and puncture group (CLP, n = 30), GW501516 group (CLP+GW, n = 25), which underwent CLP and were subcutaneously injected with the PPAR-β/δ agonist GW501516 (0.05 mg/100 g body weight). Survival was monitored to 24 hours after operation. Blood pressure, serum creatinine, blood urea nitrogen, aspartate aminotrasferase and alanine aminotrasferase were measured after CLP. Concentrations of tumor necrosis factor α (TNF-α) and interleukin (IL)-1β in serum were detected by enzyme linked immunosorbent assay (ELISA) kits. Lung tissue samples were stained with H&E and scored according to the degree of inflammation. Bacterial colonies were counted in the peritoneal fluid. Alveolar macrophages were cultured and incubated with GW501516 (0.15 µmol/L) and PPARβ/δ adenovirus and then treated with Lipopolysaccharide (2 µg/ml) for 2 hours. The TNF-α, IL-1β and IL-6 RNA in lung and alveolar macrophages were determined by real-time PCR. Phosphorylation of signal transducer and activator of transcription 3 (STAT3) in lung and alveolar macrophages was detected by Western blotting.

RESULTS

GW501516 significantly increased the survival of septic rats, decreased histological damage of the lungs, reduced inflammatory cytokines in serum and lung tissues of septic rats and did not increase counts of peritoneal bacteria. In vitro, GW501516 and over-expression of PPARβ/δ attenuated gene expression of TNF-α, IL-1β and IL-6 in alveolar macrophages. Both in vivo and in vitro, PPARβ/δ inhibited the phosphorylation of STAT3.

CONCLUSION

PPARβ/δ plays a protective role in sepsis induced ALI via suppressing excessive inflammation.

摘要

背景

急性肺损伤(ALI)和急性呼吸窘迫综合征(ARDS)是脓毒症诱发多器官功能衰竭过程中的起始阶段。全身过度炎症反应是目前公认的脓毒症发病机制。多项研究提示过氧化物酶体增殖物激活受体-β/δ(PPAR-β/δ)在相关炎症性疾病中具有保护作用。但PPARβ/δ在ALI中的作用仍不明确。本研究旨在探讨PPARβ/δ在脓毒症诱导的ALI中的作用及可能机制。

方法

采用盲肠结扎穿孔术(CLP)建立脓毒症模型。将大鼠随机分为四组,即对照组(CON,n = 6)、假手术组(SHAM,n = 12)、盲肠结扎穿孔组(CLP,n = 30)、GW501516组(CLP+GW,n = 25),CLP组大鼠行CLP手术并皮下注射PPAR-β/δ激动剂GW501516(0.05 mg/100 g体重)。术后监测24小时存活率。CLP术后测量血压、血清肌酐、血尿素氮、天冬氨酸转氨酶和丙氨酸转氨酶。采用酶联免疫吸附测定(ELISA)试剂盒检测血清中肿瘤坏死因子α(TNF-α)和白细胞介素(IL)-1β浓度。肺组织样本行苏木精-伊红(H&E)染色并根据炎症程度评分。计数腹腔液中的细菌菌落。培养肺泡巨噬细胞,用GW501516(0.15 µmol/L)和PPARβ/δ腺病毒孵育,然后用脂多糖(2 µg/ml)处理2小时。采用实时聚合酶链反应(PCR)检测肺组织和肺泡巨噬细胞中TNF-α、IL-1β和IL-6的RNA。采用蛋白质印迹法检测肺组织和肺泡巨噬细胞中信号转导子和转录激活子3(STAT3)的磷酸化水平。

结果

GW501516显著提高脓毒症大鼠的存活率,减轻肺组织学损伤,降低脓毒症大鼠血清和肺组织中的炎症细胞因子水平,且不增加腹腔细菌计数。在体外,GW501516和PPARβ/δ过表达减弱肺泡巨噬细胞中TNF-α、IL-1β和IL-6的基因表达。在体内和体外,PPARβ/δ均抑制STAT3的磷酸化。

结论

PPARβ/δ通过抑制过度炎症反应在脓毒症诱导的ALI中发挥保护作用。

相似文献

1
Effects of peroxisome proliferator-activated receptor-β/δ on sepsis induced acute lung injury.过氧化物酶体增殖物激活受体-β/δ对脓毒症诱导的急性肺损伤的影响。
Chin Med J (Engl). 2014;127(11):2129-37.
2
The peroxisome proliferator-activated receptor β/δ (PPARβ/δ) agonist GW501516 prevents TNF-α-induced NF-κB activation in human HaCaT cells by reducing p65 acetylation through AMPK and SIRT1.过氧化物酶体增殖物激活受体 β/δ(PPARβ/δ)激动剂 GW501516 通过 AMPK 和 SIRT1 减少 p65 乙酰化来防止 TNF-α 诱导的人 HaCaT 细胞中 NF-κB 的激活。
Biochem Pharmacol. 2011 Feb 15;81(4):534-43. doi: 10.1016/j.bcp.2010.12.004. Epub 2010 Dec 10.
3
Rosiglitazone induces interleukin-1 receptor antagonist in interleukin-1beta-stimulated rat synovial fibroblasts via a peroxisome proliferator-activated receptor beta/delta-dependent mechanism.罗格列酮通过过氧化物酶体增殖物激活受体β/δ依赖性机制在白细胞介素-1β刺激的大鼠滑膜成纤维细胞中诱导白细胞介素-1受体拮抗剂的产生。
Arthritis Rheum. 2005 Mar;52(3):759-69. doi: 10.1002/art.20868.
4
Curcumin protects against sepsis-induced acute lung injury in rats.姜黄素可预防大鼠脓毒症诱导的急性肺损伤。
J Surg Res. 2012 Jul;176(1):e31-9. doi: 10.1016/j.jss.2011.11.1032. Epub 2011 Dec 24.
5
Losartan prevents sepsis-induced acute lung injury and decreases activation of nuclear factor kappaB and mitogen-activated protein kinases.氯沙坦可预防脓毒症诱导的急性肺损伤,并降低核因子κB和丝裂原活化蛋白激酶的激活。
Shock. 2009 May;31(5):500-6. doi: 10.1097/SHK.0b013e318189017a.
6
Protective role of peroxisome proliferator-activated receptor β/δ in acute lung injury induced by prolonged hyperbaric hyperoxia in rats.过氧化物酶体增殖物激活受体β/δ在大鼠长时间高压高氧诱导的急性肺损伤中的保护作用
Respir Physiol Neurobiol. 2014 Aug 1;199:9-18. doi: 10.1016/j.resp.2014.04.004. Epub 2014 Apr 26.
7
The peroxisome proliferator-activated receptor (PPAR) β/δ agonist GW501516 inhibits IL-6-induced signal transducer and activator of transcription 3 (STAT3) activation and insulin resistance in human liver cells.过氧化物酶体增殖物激活受体 (PPAR)β/δ 激动剂 GW501516 抑制白细胞介素 6(IL-6)诱导的信号转导子和转录激活子 3(STAT3)激活以及人肝细胞中的胰岛素抵抗。
Diabetologia. 2012 Mar;55(3):743-51. doi: 10.1007/s00125-011-2401-4. Epub 2011 Dec 17.
8
Heat Shock Protein A12B Protects Vascular Endothelial Cells Against Sepsis-Induced Acute Lung Injury in Mice.热休克蛋白A12B保护小鼠血管内皮细胞免受脓毒症诱导的急性肺损伤。
Cell Physiol Biochem. 2017;42(1):156-168. doi: 10.1159/000477308. Epub 2017 May 25.
9
Pioglitazone attenuates lung injury by modulating adipose inflammation.吡格列酮通过调节脂肪组织炎症减轻肺损伤。
J Surg Res. 2014 Jun 15;189(2):295-303. doi: 10.1016/j.jss.2014.03.007. Epub 2014 Mar 12.
10
Delayed activation of PPAR-β/δ improves long-term survival in mouse sepsis: effects on organ inflammation and coagulation.过继激活 PPAR-β/δ可改善脓毒症小鼠的长期生存率:对器官炎症和凝血的影响。
Innate Immun. 2018 May;24(4):262-273. doi: 10.1177/1753425918771748. Epub 2018 Apr 26.

引用本文的文献

1
Nuclear receptors in health and disease: signaling pathways, biological functions and pharmaceutical interventions.健康与疾病中的核受体:信号通路、生物学功能及药物干预
Signal Transduct Target Ther. 2025 Jul 28;10(1):228. doi: 10.1038/s41392-025-02270-3.
2
Integrated Metabolomics and Lipidomics Analysis Reveals the Mechanism Behind the Action of Chiglitazar on the Protection Against Sepsis-Induced Acute Lung Injury.整合代谢组学和脂质组学分析揭示了吡格列酮预防脓毒症诱导的急性肺损伤作用背后的机制。
Metabolites. 2025 Apr 25;15(5):290. doi: 10.3390/metabo15050290.
3
PPARD May Play a Protective Role against the Development of Schizophrenia.
过氧化物酶体增殖物激活受体δ可能对精神分裂症的发展起到保护作用。
PPAR Res. 2020 Aug 7;2020:3480412. doi: 10.1155/2020/3480412. eCollection 2020.
4
Macrophage nuclear receptors: Emerging key players in infectious diseases.巨噬细胞核受体:感染性疾病的新兴关键因素。
PLoS Pathog. 2019 Mar 21;15(3):e1007585. doi: 10.1371/journal.ppat.1007585. eCollection 2019 Mar.
5
Protective Effects of Live Combined and in Polymicrobial Sepsis Through Modulating Activation and Transformation of Macrophages and Mast Cells.活菌联合制剂通过调节巨噬细胞和肥大细胞的激活与转化对多微生物败血症的保护作用
Front Pharmacol. 2019 Jan 21;9:1506. doi: 10.3389/fphar.2018.01506. eCollection 2018.
6
Identification of Haplotype Tag Single-Nucleotide Polymorphisms within the PPAR Family Genes and Their Clinical Relevance in Patients with Major Trauma.过氧化物酶体增殖物激活受体(PPAR)家族基因内单倍型标签单核苷酸多态性的鉴定及其在严重创伤患者中的临床相关性
Int J Environ Res Public Health. 2016 Mar 26;13(4):374. doi: 10.3390/ijerph13040374.
7
Targeting Peroxisome Proliferator-Activated Receptor-β/δ (PPARβ/δ) for Cancer Chemoprevention.靶向过氧化物酶体增殖物激活受体-β/δ(PPARβ/δ)用于癌症化学预防。
Curr Pharmacol Rep. 2015;1(2):121-128. doi: 10.1007/s40495-015-0026-x.